找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Metallic Nanostructures; From Controlled Synt Yujie Xiong,Xianmao Lu Book 2015 Springer International Publishing Switzerland 2015 Bimetalli

[復(fù)制鏈接]
樓主: Dopamine
21#
發(fā)表于 2025-3-25 05:54:30 | 只看該作者
22#
發(fā)表于 2025-3-25 10:41:25 | 只看該作者
Zhenmeng Pengpeutic design to optimize siRNA potency and reduce off-targeThe enormous potential of siRNA as a therapeutic has led to an explosion of interest from the scientific community. There has been intense interest from Big Pharma to capitalise on this new technology but the fact remains that delivery is a
23#
發(fā)表于 2025-3-25 12:44:48 | 只看該作者
W. David Wei,Brendan C. Sweeny,Jingjing Qiu,Joseph S. DuChenepeutic design to optimize siRNA potency and reduce off-targeThe enormous potential of siRNA as a therapeutic has led to an explosion of interest from the scientific community. There has been intense interest from Big Pharma to capitalise on this new technology but the fact remains that delivery is a
24#
發(fā)表于 2025-3-25 16:23:36 | 只看該作者
Shan Zhou,Yujie Xiongpeutic design to optimize siRNA potency and reduce off-targeThe enormous potential of siRNA as a therapeutic has led to an explosion of interest from the scientific community. There has been intense interest from Big Pharma to capitalise on this new technology but the fact remains that delivery is a
25#
發(fā)表于 2025-3-25 21:59:34 | 只看該作者
26#
發(fā)表于 2025-3-26 03:46:38 | 只看該作者
Ran Long,Yujie Xionge. Relevant chemical modifications also include conjugated targeting ligands to assist ON delivery to specific cell types. Chemical modifications are most beneficial for therapeutically relevant ONs, as they serve to enhance target binding, increase drug longevity, facilitate cell-specific targeting
27#
發(fā)表于 2025-3-26 05:20:44 | 只看該作者
28#
發(fā)表于 2025-3-26 12:29:36 | 只看該作者
Yanglong Hou,Jing Yu,Wenlong Yangintracellular and extracellular barriers. The reader will gain an insight into RNA interference from the cellular mechanisms to screening to siRNA design right through to diagnostic and therapeutic applications.978-1-4899-9319-9978-1-4614-4744-3Series ISSN 2192-6204 Series E-ISSN 2192-6212
29#
發(fā)表于 2025-3-26 14:49:38 | 只看該作者
Zhenmeng Pengintracellular and extracellular barriers. The reader will gain an insight into RNA interference from the cellular mechanisms to screening to siRNA design right through to diagnostic and therapeutic applications.978-1-4899-9319-9978-1-4614-4744-3Series ISSN 2192-6204 Series E-ISSN 2192-6212
30#
發(fā)表于 2025-3-26 17:53:41 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-25 18:12
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
镇安县| 阿拉善右旗| 麻城市| 新蔡县| 华安县| 五常市| 建阳市| 武冈市| 柘荣县| 松桃| 吉林市| 阿拉善左旗| 沧源| 新安县| 平邑县| 张家界市| 镇平县| 稷山县| 平远县| 肃宁县| 林州市| 银川市| 邯郸县| 五峰| 吕梁市| 乐山市| 景谷| 阿勒泰市| 彭泽县| 烟台市| 宁强县| 会泽县| 阿克| 晴隆县| 镇康县| 徐水县| 抚宁县| 始兴县| 象山县| 建平县| 德格县|